Concurrent Investment Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362K Buy
4,588
+728
+19% +$61.9K ﹤0.01% 1578
2026
Q1
$333K Buy
3,860
+1,132
+41% +$102K ﹤0.01% 1424
2025
Q4
$238K Buy
+2,728
New +$207K ﹤0.01% 1539

Other funds holding GMED

Concurrent Investment Advisors's GMED Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Globus Medical (GMED) stake by 19% in Q2 2026, buying an estimated $61.9K and bringing the position to 4,588 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

Concurrent Investment Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Concurrent Investment Advisors held 4,588 shares of Globus Medical worth $362K as of Q2 2026.
  • Concurrent Investment Advisors bought 728 Globus Medical shares in Q2 2026, an estimated $61.9K.
  • Globus Medical made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1578 holding.
  • Concurrent Investment Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.